Creative Diagnostics is proud to announce Plaque Reduction Assay services to support antiviral research. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive suite of Plaque Reduction Assay services to support antiviral research. These new solutions offer researchers Read more…
Creative Diagnostics announces its new line of Norovirus VLP Antigens for in vitro diagnostics and vaccine research. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line of Norovirus VLP Antigens to accelerate in vitro diagnostics and vaccine research. Read more…
Creative Diagnostics launches comprehensive line of Fumonisin Test Reagents, including conjugates, antibodies and test kits. Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, announced the launch of its comprehensive line of Fumonisin Test Reagents, including Read more…
Creative Diagnostics announces the launch of ELISA Based Assays for vaccine development and bioprocess applications. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine development and bioprocess applications. Vaccine development involves Read more…
Creative Diagnostics announces the launch of its Kanamycin ELISA Kit. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the launch of its cutting-edge Kanamycin ELISA Kit. This innovative kit enables the rapid and accurate detection of kanamycin residues in various biological products. Read more…